Conclusion. Ceftobiprole is a novel, broad-spectrum, parenteral cephalosporin undergoing Phase III clinical trials. Its broad spectrum of activity makes it a candidate for monotherapy of cSSSIs ...

Many authors have suggested using a cephalosporin as an alternative to penicillin. Casey and Pichichero performed a meta-analysis of 35 randomized, controlled trials comparing penicillin with ...

California Insurance Commissioner Ricardo Lara announced the enforcement of a regulation aimed at expanding insurance coverage in wildfire-prone areas of the state, where insurers have fled and ...

These will slot into Shionogi’s portfolio alongside Fetroja (cefiderocol), billed as the first and only siderophore cephalosporin antibiotic that has a novel mechanism for penetrating the outer ...